ID26290A - Bentuk-bentuk kristal dari is [1alfa(2s*, 3r*), 9alfa] 6,10-diokso-n-(2-etoksi-5-okso-tetrahidro-3-furanil)-9 [[ (1-isokuinolil)karbonil] amino]oktahidro-6h-piridazino [1,2-a] [1,2] diazepin-1-karboksamida - Google Patents

Bentuk-bentuk kristal dari is [1alfa(2s*, 3r*), 9alfa] 6,10-diokso-n-(2-etoksi-5-okso-tetrahidro-3-furanil)-9 [[ (1-isokuinolil)karbonil] amino]oktahidro-6h-piridazino [1,2-a] [1,2] diazepin-1-karboksamida

Info

Publication number
ID26290A
ID26290A IDW20002015A ID20002015A ID26290A ID 26290 A ID26290 A ID 26290A ID W20002015 A IDW20002015 A ID W20002015A ID 20002015 A ID20002015 A ID 20002015A ID 26290 A ID26290 A ID 26290A
Authority
ID
Indonesia
Prior art keywords
oktahidro
isoquuololil
etoksi
dioxso
cararoxox
Prior art date
Application number
IDW20002015A
Other languages
English (en)
Indonesian (id)
Inventor
Jean-Yves Godard
Valerie Rognon
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of ID26290A publication Critical patent/ID26290A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
IDW20002015A 1998-04-08 1999-04-07 Bentuk-bentuk kristal dari is [1alfa(2s*, 3r*), 9alfa] 6,10-diokso-n-(2-etoksi-5-okso-tetrahidro-3-furanil)-9 [[ (1-isokuinolil)karbonil] amino]oktahidro-6h-piridazino [1,2-a] [1,2] diazepin-1-karboksamida ID26290A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9804367A FR2777279B1 (fr) 1998-04-08 1998-04-08 Nouvelles formes cristallines du 1s-[1alpha(2s*,3r*), 9 alpha] 6,10-dioxo-n-(2-ethoxy-5-oxo-tetrahydro-3-furanyl) -9[[(1-isoquinolyl)carbonyl]amino]octohydro-6h-pyridazino [1,2-a][1,2]diazepine-1-carboxamide

Publications (1)

Publication Number Publication Date
ID26290A true ID26290A (id) 2000-12-14

Family

ID=9524993

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20002015A ID26290A (id) 1998-04-08 1999-04-07 Bentuk-bentuk kristal dari is [1alfa(2s*, 3r*), 9alfa] 6,10-diokso-n-(2-etoksi-5-okso-tetrahidro-3-furanil)-9 [[ (1-isokuinolil)karbonil] amino]oktahidro-6h-piridazino [1,2-a] [1,2] diazepin-1-karboksamida

Country Status (38)

Country Link
US (2) US6544977B1 (bg)
EP (1) EP1070083B1 (bg)
JP (1) JP2002511485A (bg)
KR (1) KR100582981B1 (bg)
CN (1) CN1202123C (bg)
AP (1) AP1734A (bg)
AR (1) AR018328A1 (bg)
AT (1) ATE315044T1 (bg)
AU (1) AU758042B2 (bg)
BG (1) BG64736B1 (bg)
BR (1) BR9909549A (bg)
CA (1) CA2325629C (bg)
CU (1) CU23055A3 (bg)
CZ (1) CZ299744B6 (bg)
DE (1) DE69929315T2 (bg)
DK (1) DK1070083T3 (bg)
EA (1) EA002761B1 (bg)
EE (1) EE04467B1 (bg)
ES (1) ES2253880T3 (bg)
FR (1) FR2777279B1 (bg)
GE (1) GEP20032974B (bg)
HK (1) HK1038575B (bg)
HR (1) HRP20000665B1 (bg)
HU (1) HU227561B1 (bg)
ID (1) ID26290A (bg)
IL (2) IL138818A (bg)
ME (1) ME01627B (bg)
NO (1) NO327995B1 (bg)
NZ (1) NZ507199A (bg)
PL (1) PL197016B1 (bg)
RS (1) RS49916B (bg)
SI (1) SI1070083T1 (bg)
SK (1) SK286267B6 (bg)
TR (1) TR200002914T2 (bg)
TW (1) TW522152B (bg)
UA (1) UA71563C2 (bg)
WO (1) WO1999052935A1 (bg)
ZA (1) ZA200005438B (bg)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8198450B2 (en) * 2006-06-30 2012-06-12 Novartis Ag Quinolinone derivatives and their pharmaceutical compositions
AU2014277867B2 (en) * 2007-12-04 2016-11-03 Arbutus Biopharma Corporation Targeting lipids

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204261B1 (en) * 1995-12-20 2001-03-20 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β Converting enzyme inhibitors
US5552400A (en) * 1994-06-08 1996-09-03 Sterling Winthrop Inc. Fused-bicyclic lactams as interleukin-1β converting enzyme inhibitors

Also Published As

Publication number Publication date
BG104829A (bg) 2001-05-31
US20030171365A1 (en) 2003-09-11
US6544977B1 (en) 2003-04-08
EE200000586A (et) 2002-02-15
NO327995B1 (no) 2009-11-02
ME01627B (me) 2008-09-29
FR2777279A1 (fr) 1999-10-15
UA71563C2 (uk) 2004-12-15
DE69929315T2 (de) 2006-08-17
FR2777279B1 (fr) 2004-08-13
HRP20000665A2 (en) 2001-08-31
CZ20003678A3 (cs) 2001-02-14
SI1070083T1 (sl) 2006-04-30
CA2325629C (fr) 2013-01-22
YU60800A (sh) 2002-11-15
JP2002511485A (ja) 2002-04-16
PL197016B1 (pl) 2008-02-29
NZ507199A (en) 2002-12-20
CU23055A3 (es) 2005-06-24
ATE315044T1 (de) 2006-02-15
AR018328A1 (es) 2001-11-14
DK1070083T3 (da) 2006-05-15
NO20005060D0 (no) 2000-10-06
CN1202123C (zh) 2005-05-18
GEP20032974B (en) 2003-05-27
RS49916B (sr) 2008-09-29
IL138818A (en) 2008-11-26
AP1734A (en) 2007-03-22
ES2253880T3 (es) 2006-06-01
US6946459B2 (en) 2005-09-20
EA200001047A1 (ru) 2001-04-23
HK1038575A1 (en) 2002-03-22
ZA200005438B (en) 2002-01-07
NO20005060L (no) 2000-10-06
EE04467B1 (et) 2005-04-15
BG64736B1 (bg) 2006-01-31
AP2000001939A0 (en) 2000-12-31
AU758042B2 (en) 2003-03-13
SK14882000A3 (sk) 2001-04-09
TW522152B (en) 2003-03-01
CA2325629A1 (fr) 1999-10-21
EA002761B1 (ru) 2002-08-29
PL343350A1 (en) 2001-08-13
TR200002914T2 (tr) 2001-02-21
KR20010034759A (ko) 2001-04-25
AU3041699A (en) 1999-11-01
WO1999052935A1 (fr) 1999-10-21
EP1070083B1 (fr) 2006-01-04
HUP0101586A2 (hu) 2001-11-28
BR9909549A (pt) 2000-12-12
HU227561B1 (en) 2011-08-29
IL168047A (en) 2011-10-31
EP1070083A1 (fr) 2001-01-24
KR100582981B1 (ko) 2006-05-24
DE69929315D1 (de) 2006-03-30
HK1038575B (zh) 2006-01-06
CZ299744B6 (cs) 2008-11-12
SK286267B6 (sk) 2008-06-06
CN1305491A (zh) 2001-07-25
HUP0101586A3 (en) 2002-11-28
HRP20000665B1 (en) 2008-01-31

Similar Documents

Publication Publication Date Title
ID25660A (id) Teripatide kristal
ID25629A (id) AMINA BISIKLIK (Pecahan dari P-961362)
IL128653A0 (en) Substituted N-((aminoiminomethyl or aminomethyl) phenyyl) propyl amides
ID25534A (id) Glucagon-seperti kristal peptida-1
DK0906094T3 (da) Substituerede N-[(aminoiminomethyl- eller aminomethyl)phenyl]propylamider
NO983603D0 (no) Substituerte sulfonsyre N-£(aminoiminometyl)-fenylalkyl|-azaheterocyklamid-forbindelser
BR9408087A (pt) Recuperação de um aminoácido
CA2245267A1 (en) Crystal form of n-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
FI960428A0 (fi) Meningokokin reseptoritransferriinin Tbp2-osia
NZ332397A (en) Sulfonic acid amide derivatives useful as intermediates in the preparation of benzothiazolone compounds
ID23371A (id) Pemulihan heksametilenediamina dari campuran-campuran yang sama
NO20013142D0 (no) Substituerte (aminoiminometyl eller aminometyl)benzoheteroarylforbindelser
DK1124797T3 (da) N-Arylsulfonyl-aminosyre-omega-amider
ID25452A (id) Produksi poliamida dari senyawa amino karboksilat
PT1121375E (pt) Composto de elevada pureza de (7alfa, 17alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5(10)-en-20-in-3-ona
ID26290A (id) Bentuk-bentuk kristal dari is [1alfa(2s*, 3r*), 9alfa] 6,10-diokso-n-(2-etoksi-5-okso-tetrahidro-3-furanil)-9 [[ (1-isokuinolil)karbonil] amino]oktahidro-6h-piridazino [1,2-a] [1,2] diazepin-1-karboksamida
AU9755198A (en) Production of stretched ion exchange membranes
ID24267A (id) Enansiomer-enansiomer dari 4-[[(sianoimino) [(1,2,2-trimetilpropil) amino] metil] amino] benzonitril
ID27066A (id) Proses yang disempurnakan untuk ko-produksi dari 6-aminokapronitril dan heksametilendiamina
PL338248A1 (en) Application of mixtures of electrolytes as sequestering agents
AU8027700A (en) Use of n-'n-(3,3 dimethylbutyl)-l-alpha-aspartyl-l-phenylalanine 1-methyl ester (neotame) to modify mouthfeel perception
ID21650A (id) Suspensi farmasi yang terdiri dari nevirapin hemihidrat
ID25777A (id) Sekumpulan proses untuk memproduksi poliamida dari aminonitril
AU4374199A (en) Purification of battery electrolytes by means of physical adsorption
AU8985298A (en) Novel sulphonamide derived from substituted anilines useful as medicines